The primary objective of the project is to obtain a clear understanding of the mechanisms involved in the transport of a unique amino acid, taurine, across the human placenta. Taurine, though a non-protein amino acid, is the most abundant free amino in several tissues (e.g. brain, heart, and retina) of the human fetus. In animals, induction of taurine deficiency in the mother during pregnancy produces deleterious effects on the developing fetus, causing functional impairment of those organs which accumulate high levels of taurine. The effects of taurine deficiency in utero include retinal degeneration, cardiac myopathy and impairment of cerebellar development. These studies indicate that taurine plays an important role in the growth and development of the fetus. Paradoxically however, neither the human fetus nor the human placenta can synthesize taurine endogenously. Maternal-to-fetal transfer across the placenta is the only mechanisms available for the fetus to obtain this important nutrient. A model is proposed for the transport of taurine across the placenta according to which the syncytiotrophoblast expresses two similar, yet distinct, taurine transporters, one in the maternal-facing brush border membrane and the other in the fetal-facing basal membrane and a functional coordination between these two transporters bring about the transfer of taurine from mother to fetus. The project seeks to obtain supporting evidence for this model, by establishing the molecular and biochemical identity of these two transporters. This goal will be achieved by isolating the cDNAs encoding these transporters from a human placental cDNA library and by functionally expressing the cloned transporters in mammalian cells and in Xenopus laevis oocytes. Polyclonal and monoclonal antibodies against the cloned transport proteins will be generated to be used in immunohistochemical studies to establish the polarized localization of the two taurine transporters in the syncytiotrophoblast. Characterization of taurine transport across the brush border and basal membranes will also be done with purified membrane vesicles from normal placentas. These studies will be complemented with an intact cell system in which placental choriocarcinoma cells will be grown on permeable filters allowing access to the brush border and basolateral membranes for differential assessment and characterization of taurine transport across these membranes. Another goal of the project is to investigate the hormonal regulation of the placental taurine transporter(s) and the cellular mechanisms involved therein. It is proposed that the transporter is regulated by posttranslational modification involving phosphorylation and that protein kinase C and calcineurin (a Ca2+- calmodulin-dependent phosphoprotein phosphatase) participate in this process. The taurine transporter cDNA(s) and the antitransporter antibodies will provide excellent experimental tools for these studies. This project will result in a thorough understanding of the molecular and cellular mechanisms responsible for the maternal-to-fetal transfer of taurine across the human placenta.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Research Project (R01)
Project #
2R01HD024451-06A1
Application #
2199175
Study Section
Human Embryology and Development Subcommittee 1 (HED)
Project Start
1989-04-01
Project End
1997-11-30
Budget Start
1994-12-01
Budget End
1995-11-30
Support Year
6
Fiscal Year
1995
Total Cost
Indirect Cost
Name
Medical College of Georgia (MCG)
Department
Biochemistry
Type
Schools of Medicine
DUNS #
City
Augusta
State
GA
Country
United States
Zip Code
30912
Torres-Zamorano, V; Leibach, F H; Ganapathy, V (1998) Sodium-dependent homo- and hetero-exchange of neutral amino acids mediated by the amino acid transporter ATB degree. Biochem Biophys Res Commun 245:824-9
Wu, X; Prasad, P D; Leibach, F H et al. (1998) cDNA sequence, transport function, and genomic organization of human OCTN2, a new member of the organic cation transporter family. Biochem Biophys Res Commun 246:589-95
Prasad, P D; Wang, H; Kekuda, R et al. (1998) Cloning and functional expression of a cDNA encoding a mammalian sodium-dependent vitamin transporter mediating the uptake of pantothenate, biotin, and lipoate. J Biol Chem 273:7501-6
Kekuda, R; Torres-Zamorano, V; Fei, Y J et al. (1997) Molecular and functional characterization of intestinal Na(+)-dependent neutral amino acid transporter B0. Am J Physiol 272:G1463-72
Prasad, P D; Ramamoorthy, S; Leibach, F H et al. (1997) Characterization of a sodium-dependent vitamin transporter mediating the uptake of pantothenate, biotin and lipoate in human placental choriocarcinoma cells. Placenta 18:527-33
Roque, A S; Prasad, P D; Bhatia, J S et al. (1996) Sodium-dependent high-affinity binding of carnitine to human placental brush border membranes. Biochim Biophys Acta 1282:274-82
Prasad, P D; Huang, W; Ramamoorthy, S et al. (1996) Sodium-dependent carnitine transport in human placental choriocarcinoma cells. Biochim Biophys Acta 1284:109-17
Kekuda, R; Prasad, P D; Fei, Y J et al. (1996) Cloning of the sodium-dependent, broad-scope, neutral amino acid transporter Bo from a human placental choriocarcinoma cell line. J Biol Chem 271:18657-61
Jayanthi, L D; Ramamoorthy, S; Mahesh, V B et al. (1995) Substrate-specific regulation of the taurine transporter in human placental choriocarcinoma cells (JAR). Biochim Biophys Acta 1235:351-60
Yang-Feng, T L; Ma, Y Y; Liang, R et al. (1995) Assignment of the human folate transporter gene to chromosome 21q22.3 by somatic cell hybrid analysis and in situ hybridization. Biochem Biophys Res Commun 210:874-9

Showing the most recent 10 out of 37 publications